P53 Mutations in Gastric Carcinomas
Author Information
Author(s): R. Seruca, L. David, R. Holm, J.M. Nesland, B.M. Fangan, S. Castedo, M. Sobrinho-Simoes, A.-L. B0rresen
Primary Institution: Medical Faculty of Porto, Porto, Portugal
Hypothesis
The study aims to evaluate p53 overexpression and allelic loss at 17p in gastric carcinomas.
Conclusion
The prevalence of p53 mutations in gastric carcinomas is similar to that observed in other cases of gastric cancer, but lower than in colon carcinomas.
Supporting Evidence
- Four cases showed immunoreactivity for p53 protein.
- Nine cases showed allelic loss for the pYNZ22.1 marker.
- Three out of nine cases studied revealed p53 mutations.
Takeaway
The study looked at stomach cancer samples to see if there were changes in a gene called p53, which helps control cell growth. They found some changes, but not as many as in colon cancer.
Methodology
The study involved immunohistochemical analysis and DNA analysis of gastric carcinoma samples to assess p53 protein overexpression, allelic loss, and mutations.
Potential Biases
Potential sampling bias due to contamination by non-neoplastic cells may affect results.
Limitations
The small number of analyzed cases limits the ability to draw definite conclusions.
Statistical Information
P-Value
0.099
Statistical Significance
p=0.099
Want to read the original?
Access the complete publication on the publisher's website